Shift Bioscience Establishes North American Facilities to Advance AI-Powered Rejuvenation Research
Shift Bioscience, a biotech company leveraging AI-powered virtual cells to combat age-related diseases, announced on Tuesday, February 18, the establishment of a new North American team and facilities. This expansion aims to advance the development of the Company's platform for discovering rejuvenation gene targets by tapping into Toronto's AI ecosystem. Also Read: AI-Driven Medicine Could Offer Hope for Snakebite Treatment Leveraging Toronto's AI Ecosystem "By expanding into this AI hub,... Read More